Sell RIM!: Against ...
Health Care: Drugs
Cambrex Corporation (CBM: NYSE)
$7.25 0.17 | 2.40%
06/04/12 - 04:01 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 7.08 |
| 52 Week High | 8.44 |
| 52 Week Low | 3.87 |
| Avg. Daily Vol. (Mil) | 0.13 |
| Beta (3 year) | 0.51 |
| Share Related Items | |
| Mkt Cap (Mil) | 209.72 |
| Shares Out (Mil) | 29.62 |
| Float (Mil) | 29.02 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.00 |
| Current Ratio | 2.30 |
| LT Debt/ Equity | 0.74 |
| Total Debt / Equity | 0.74 |
| Valuation Ratios | |
| Price Earnings | 13.90 |
| Price/Sales | 0.79 |
| Price/Book | 1.85 |
| Price/Cash Flow | 5.50 |
| Per Share Data | |
| Earnings | 0.51 |
| Sales | 8.96 |
| Book Value | 3.83 |
| Cash Flow | 1.29 |
| Business Summary | |
|---|---|
| Cambrex Corporation is a life sciences company that provides essential products and services to accelerate drug discovery, development and manufacturing processes for human therapeutics. | |
| General Information | |
| One Meadowlands Plaza
East Rutherford, NJ 07073 |
|
| www.cambrex.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 833 | |
| CEO: Steven M. Klosk | |
| Short Interest | |
| Current Month (Mil) | 0.81 |
| Previous Month (Mil) | 0.80 |
| Short Interest Ratio (Days) | 6.00 |
| Management Effectiveness | |
| Return on Equity | 13.50 |
| Return on Assets | 4.60 |
| Return on Investments | 7.70 |
| Profitability | |
| Gross Margin | 38.40 |
| EBIT Margin | 10.00 |
| Profit Margin | 5.80 |
Portfolios with CBM
- Portfolio NameUser Type
- ContributorStocks At New 52-Week Highs...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserPART 2 JPMorgan 28th Annual...
- UserPART 3 JPMorgan 27th Annual...
- UserRocket Stocks For The Week ...
- UserValue Seeker
- UserPART 3 JPMorgan 26th Annual...
- Userjmj2321 Portfolio 1
- Userxfirst portfoliox
- UserStian Trellevik Biotech bet
Latest CBM Headlines from TheStreet
- Cambrex Stock Gaps Up On Today's Open (CBM) 05.04.12 | 09:05 am
- Cambrex Corporation Stock Upgraded (CBM) 02.08.12 | 06:02 am
- NYSE Stocks Posting Largest Percentage Decreases 02.07.12 | 06:02 pm
- NYSE Stocks Posting Largest Percentage Decreases 02.07.12 | 01:02 pm
- Cambrex Stock Gaps Down On Today's Open (CBM) 02.07.12 | 09:02 am
- Cambrex Stock Hits New 52-Week High (CBM) 01.27.12 | 01:01 pm
- NYSE Stocks Posting Largest Percentage Increases 11.07.11 | 06:11 pm
- NYSE Stocks Posting Largest Percentage Increases 11.07.11 | 01:11 pm
- Cambrex Stock Soars (CBM) 08.03.11 | 10:08 am
- Cambrex Stock Soars (CBM) 05.12.11 | 04:05 pm
Press Releases for CBM
- Cambrex To Present At UBS 22nd Annual Global Healthcare Services Conference - PR Newswire 02.06.12 | 03:02 pm
- Cambrex And Tillotts Enter A Development And Commercialization Agreement For Proprietary 5-ASA-Based Technology - PR Newswire 07.06.11 | 08:07 am
- Cambrex Zenara Manufacturing Facility Receives European GMP Approval - PR Newswire 01.18.11 | 09:01 am
- Shawn P. Cavanagh Appointed Chief Operating Officer Of Cambrex - PR Newswire 01.07.11 | 01:01 pm
- Cambrex Zenara Supplies Product For Launch Of Nicorette® In India - PR Newswire 01.06.11 | 03:01 pm
- Cambrex Acquires Stake In Zenara Pharma - PR Newswire 11.02.10 | 04:11 pm
- Cambrex Acquires IEP GmbH - PR Newswire 03.22.10 | 01:03 pm
- Cambrex Reports Fourth Quarter And Full Year 2009 Results - PR Newswire 02.10.10 | 05:02 pm
- Cambrex Presentation At The JPMorgan Healthcare Conference To Be Webcast - PR Newswire 01.05.10 | 08:01 am
Partner Headlines for CBM
- If Europe Gets Worse, Stay Away From These 13 U.S. Stocks - Seeking Alpha 11.11.11 | 04:11 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.08.11 | 09:11 am
- 9 Small Caps With Positive Earnings Trends - Seeking Alpha 09.16.11 | 08:09 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.31.11 | 09:08 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 08.23.11 | 09:08 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 08.19.11 | 09:08 am
- Shawn P. Cavanagh Appointed Cambrex COO - Benzinga 01.07.11 | 01:01 pm
- Cambrex Acquires Stake in Zenara Pharma for $20M - Benzinga 11.02.10 | 04:11 pm
